Clinical Trials

    A Phase 2a, Multicenter, Randomized, Subject and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.

    Investigator: Michael Klebuc

    Study Coordinator: Darrel Cleere

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT05293522

    Phone: 713.441.6232

    Protocol Number: PRO00034884

    Description


    This study involves the use of an Investigational Product called NTX-001. It is a product used in the repair of nerve injuries. It is used in the operating room. The main purposes of this study are to 1) see how safe NTX-001 is when used in nerve repair and, 2) see if your nerve becomes functional in a shorter period of time when compared to what is normally done to treat nerve injuries.